| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera | 113 | 2024 | 774 | 10.500 |
Why?
|
| Vibrio cholerae | 89 | 2023 | 797 | 7.270 |
Why?
|
| Vibrio cholerae O1 | 54 | 2024 | 244 | 5.840 |
Why?
|
| Antibodies, Bacterial | 78 | 2024 | 1470 | 4.010 |
Why?
|
| Cholera Vaccines | 39 | 2024 | 264 | 3.540 |
Why?
|
| O Antigens | 24 | 2024 | 196 | 2.340 |
Why?
|
| Bangladesh | 75 | 2023 | 734 | 2.320 |
Why?
|
| Antigens, Bacterial | 28 | 2019 | 1155 | 1.960 |
Why?
|
| Bacterial Proteins | 46 | 2015 | 3822 | 1.900 |
Why?
|
| Vibrio cholerae O139 | 13 | 2023 | 54 | 1.790 |
Why?
|
| Immunoglobulin A | 50 | 2024 | 978 | 1.710 |
Why?
|
| Cholera Toxin | 40 | 2024 | 559 | 1.670 |
Why?
|
| Immunologic Memory | 24 | 2022 | 1354 | 1.620 |
Why?
|
| Typhoid Fever | 14 | 2020 | 195 | 1.470 |
Why?
|
| Fimbriae Proteins | 15 | 2017 | 132 | 1.470 |
Why?
|
| Gene Expression Regulation, Bacterial | 26 | 2015 | 1129 | 1.460 |
Why?
|
| Genes, Bacterial | 28 | 2012 | 1070 | 1.260 |
Why?
|
| Escherichia coli O157 | 8 | 2015 | 53 | 1.220 |
Why?
|
| Salmonella typhi | 13 | 2020 | 199 | 1.210 |
Why?
|
| Escherichia coli Proteins | 14 | 2016 | 1066 | 1.040 |
Why?
|
| Diarrhea | 19 | 2024 | 1341 | 1.030 |
Why?
|
| Feces | 20 | 2024 | 1466 | 1.000 |
Why?
|
| Immunoglobulin M | 24 | 2024 | 1529 | 0.920 |
Why?
|
| Bacterial Toxins | 20 | 2016 | 931 | 0.910 |
Why?
|
| Immunoglobulin G | 56 | 2024 | 4546 | 0.910 |
Why?
|
| Virulence | 29 | 2015 | 1295 | 0.860 |
Why?
|
| B-Lymphocytes | 23 | 2022 | 4739 | 0.860 |
Why?
|
| Bacterial Outer Membrane Proteins | 16 | 2015 | 407 | 0.820 |
Why?
|
| Caenorhabditis elegans | 13 | 2009 | 1444 | 0.750 |
Why?
|
| Cryptococcus neoformans | 7 | 2009 | 121 | 0.730 |
Why?
|
| Immunity, Mucosal | 11 | 2020 | 481 | 0.720 |
Why?
|
| Bacteremia | 10 | 2015 | 979 | 0.720 |
Why?
|
| Iron | 20 | 2001 | 1786 | 0.710 |
Why?
|
| Bacterial Typing Techniques | 5 | 2014 | 260 | 0.680 |
Why?
|
| Escherichia coli Infections | 7 | 2017 | 524 | 0.680 |
Why?
|
| Antibody-Producing Cells | 8 | 2021 | 140 | 0.650 |
Why?
|
| Endocarditis, Bacterial | 5 | 2013 | 445 | 0.610 |
Why?
|
| Enterococcus faecalis | 8 | 2004 | 247 | 0.610 |
Why?
|
| Enterotoxins | 9 | 2016 | 367 | 0.600 |
Why?
|
| Lipopolysaccharides | 19 | 2023 | 2214 | 0.580 |
Why?
|
| Genome, Bacterial | 8 | 2024 | 770 | 0.540 |
Why?
|
| Blood Group Antigens | 3 | 2023 | 187 | 0.520 |
Why?
|
| Enterotoxigenic Escherichia coli | 5 | 2017 | 32 | 0.510 |
Why?
|
| Vaccines, Conjugate | 11 | 2023 | 328 | 0.500 |
Why?
|
| Bacteriophages | 7 | 2013 | 373 | 0.490 |
Why?
|
| Infectious Disease Medicine | 1 | 2015 | 49 | 0.480 |
Why?
|
| Mutagenesis, Insertional | 11 | 2004 | 652 | 0.480 |
Why?
|
| Vaccines, Synthetic | 9 | 2009 | 617 | 0.470 |
Why?
|
| Regulon | 3 | 1999 | 71 | 0.470 |
Why?
|
| Bacterial Vaccines | 9 | 2009 | 401 | 0.460 |
Why?
|
| History of Medicine | 1 | 2014 | 42 | 0.460 |
Why?
|
| Device Approval | 1 | 2015 | 165 | 0.450 |
Why?
|
| Antibody Formation | 11 | 2024 | 1400 | 0.450 |
Why?
|
| Streptococcus mutans | 1 | 2013 | 98 | 0.430 |
Why?
|
| Receptors, Cell Surface | 9 | 1998 | 2825 | 0.420 |
Why?
|
| Escherichia coli | 19 | 2016 | 4223 | 0.420 |
Why?
|
| Vaccination | 12 | 2024 | 3360 | 0.420 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2003 | 104 | 0.410 |
Why?
|
| Adhesins, Bacterial | 4 | 2012 | 118 | 0.410 |
Why?
|
| Repressor Proteins | 10 | 2001 | 2978 | 0.410 |
Why?
|
| Disease Outbreaks | 9 | 2018 | 1759 | 0.410 |
Why?
|
| Vaccines, Attenuated | 10 | 2017 | 316 | 0.410 |
Why?
|
| DNA, Bacterial | 19 | 2015 | 1455 | 0.400 |
Why?
|
| Molecular Sequence Data | 35 | 2015 | 17628 | 0.390 |
Why?
|
| Oxazoles | 4 | 2000 | 199 | 0.380 |
Why?
|
| Government Regulation | 1 | 2015 | 526 | 0.370 |
Why?
|
| Bone Marrow Transplantation | 10 | 2004 | 2696 | 0.370 |
Why?
|
| Streptococcal Infections | 3 | 2013 | 617 | 0.370 |
Why?
|
| Antibodies, Protozoan | 4 | 2012 | 250 | 0.370 |
Why?
|
| Child, Preschool | 63 | 2024 | 42034 | 0.370 |
Why?
|
| Operon | 4 | 2000 | 369 | 0.360 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2018 | 1811 | 0.350 |
Why?
|
| Fimbriae, Bacterial | 3 | 2005 | 138 | 0.350 |
Why?
|
| Catechols | 4 | 2000 | 62 | 0.350 |
Why?
|
| Immunity, Innate | 9 | 2019 | 3046 | 0.340 |
Why?
|
| Administration, Oral | 20 | 2021 | 4044 | 0.340 |
Why?
|
| Cryptosporidiosis | 4 | 2012 | 55 | 0.340 |
Why?
|
| Disease Susceptibility | 4 | 2021 | 1791 | 0.340 |
Why?
|
| Base Sequence | 27 | 2013 | 12447 | 0.340 |
Why?
|
| Communicable Diseases | 2 | 2017 | 879 | 0.340 |
Why?
|
| Disease Models, Animal | 16 | 2021 | 18134 | 0.330 |
Why?
|
| Gene Expression Profiling | 12 | 2018 | 9388 | 0.330 |
Why?
|
| DNA-Binding Proteins | 10 | 2003 | 9590 | 0.330 |
Why?
|
| Adolescent | 74 | 2024 | 87747 | 0.330 |
Why?
|
| Serologic Tests | 3 | 2020 | 383 | 0.330 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.320 |
Why?
|
| Vaccines, Inactivated | 11 | 2023 | 180 | 0.310 |
Why?
|
| Shiga Toxins | 7 | 1999 | 40 | 0.310 |
Why?
|
| Humans | 197 | 2024 | 760261 | 0.310 |
Why?
|
| Drug Approval | 1 | 2015 | 816 | 0.310 |
Why?
|
| Helminthiasis | 1 | 2009 | 80 | 0.310 |
Why?
|
| Paratyphoid Fever | 3 | 2013 | 34 | 0.310 |
Why?
|
| Transcription Factors | 12 | 2003 | 12100 | 0.300 |
Why?
|
| Gastrointestinal Tract | 4 | 2024 | 830 | 0.300 |
Why?
|
| Drug Discovery | 1 | 2015 | 1056 | 0.290 |
Why?
|
| Adult | 91 | 2024 | 219847 | 0.290 |
Why?
|
| Antibody Specificity | 4 | 2019 | 1061 | 0.290 |
Why?
|
| Transcription, Genetic | 14 | 2007 | 7593 | 0.290 |
Why?
|
| Proteome | 5 | 2013 | 1856 | 0.280 |
Why?
|
| Mucous Membrane | 5 | 2019 | 657 | 0.280 |
Why?
|
| Genes, Regulator | 4 | 1998 | 374 | 0.280 |
Why?
|
| Child | 64 | 2024 | 79758 | 0.280 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1675 | 0.280 |
Why?
|
| Disease Transmission, Infectious | 3 | 2011 | 558 | 0.280 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3145 | 0.280 |
Why?
|
| Genetic Complementation Test | 9 | 2002 | 555 | 0.270 |
Why?
|
| Heart Valve Prosthesis | 6 | 2001 | 1494 | 0.270 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 695 | 0.270 |
Why?
|
| Systems Biology | 1 | 2010 | 479 | 0.270 |
Why?
|
| Immune Sera | 2 | 2015 | 613 | 0.270 |
Why?
|
| Cryptosporidium | 4 | 2012 | 42 | 0.270 |
Why?
|
| Neuraminidase | 3 | 2022 | 200 | 0.270 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 2359 | 0.270 |
Why?
|
| Amino Acid Sequence | 23 | 2013 | 13456 | 0.270 |
Why?
|
| Family Characteristics | 8 | 2018 | 1001 | 0.260 |
Why?
|
| Duodenum | 5 | 2022 | 486 | 0.260 |
Why?
|
| Chromosomes, Bacterial | 5 | 2013 | 280 | 0.260 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 604 | 0.260 |
Why?
|
| Intestines | 7 | 2015 | 1907 | 0.260 |
Why?
|
| Young Adult | 47 | 2021 | 58673 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 14 | 2009 | 5784 | 0.250 |
Why?
|
| Recombinant Proteins | 10 | 2016 | 6543 | 0.250 |
Why?
|
| Travel | 2 | 2001 | 786 | 0.240 |
Why?
|
| Neutropenia | 3 | 2001 | 884 | 0.240 |
Why?
|
| Prosthesis-Related Infections | 2 | 2001 | 486 | 0.240 |
Why?
|
| Endophthalmitis | 3 | 2004 | 257 | 0.240 |
Why?
|
| Vaccines, Combined | 2 | 2021 | 70 | 0.230 |
Why?
|
| Salmonella paratyphi A | 3 | 2016 | 47 | 0.230 |
Why?
|
| Female | 110 | 2022 | 391011 | 0.230 |
Why?
|
| Antibody Affinity | 3 | 2014 | 245 | 0.230 |
Why?
|
| Plasmids | 7 | 2017 | 2277 | 0.230 |
Why?
|
| Staphylococcus aureus | 5 | 2006 | 1462 | 0.230 |
Why?
|
| Immunity, Cellular | 2 | 2009 | 1558 | 0.230 |
Why?
|
| Shigella Vaccines | 1 | 2023 | 10 | 0.220 |
Why?
|
| Carrier State | 2 | 2020 | 525 | 0.220 |
Why?
|
| RNA, Bacterial | 7 | 2011 | 384 | 0.220 |
Why?
|
| Bacteriological Techniques | 2 | 2018 | 279 | 0.220 |
Why?
|
| Convalescence | 3 | 2021 | 106 | 0.220 |
Why?
|
| Fungal Proteins | 2 | 2004 | 911 | 0.220 |
Why?
|
| Male | 93 | 2022 | 359413 | 0.210 |
Why?
|
| Mice | 42 | 2023 | 81216 | 0.210 |
Why?
|
| Shigella | 1 | 2023 | 72 | 0.210 |
Why?
|
| Biological Assay | 2 | 2004 | 630 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 8 | 2018 | 6067 | 0.210 |
Why?
|
| Animals | 69 | 2023 | 167940 | 0.210 |
Why?
|
| Dysentery, Bacillary | 1 | 2023 | 76 | 0.210 |
Why?
|
| Societies, Medical | 1 | 2015 | 3903 | 0.210 |
Why?
|
| T-Lymphocytes | 7 | 2015 | 10183 | 0.210 |
Why?
|
| Ferrichrome | 2 | 2000 | 3 | 0.210 |
Why?
|
| Gene Deletion | 6 | 2013 | 2668 | 0.210 |
Why?
|
| Staphylococcus epidermidis | 3 | 2007 | 122 | 0.210 |
Why?
|
| Polymorphism, Genetic | 3 | 2011 | 4286 | 0.210 |
Why?
|
| Genetic Vectors | 7 | 2000 | 3378 | 0.210 |
Why?
|
| Enzyme-Linked Immunospot Assay | 3 | 2017 | 123 | 0.200 |
Why?
|
| Antigens, Protozoan | 3 | 2012 | 315 | 0.200 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2002 | 168 | 0.200 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1996 | 886 | 0.200 |
Why?
|
| Bacterial Adhesion | 4 | 2015 | 306 | 0.200 |
Why?
|
| Cloning, Molecular | 11 | 2002 | 4172 | 0.200 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2003 | 1275 | 0.200 |
Why?
|
| Infant | 34 | 2021 | 36030 | 0.190 |
Why?
|
| Listeriosis | 2 | 2002 | 148 | 0.190 |
Why?
|
| Entamoeba histolytica | 2 | 2000 | 29 | 0.190 |
Why?
|
| Genetic Variation | 6 | 2024 | 6540 | 0.190 |
Why?
|
| Salmonella enterica | 2 | 2016 | 75 | 0.190 |
Why?
|
| Anthozoa | 1 | 2021 | 65 | 0.190 |
Why?
|
| Phylogeny | 9 | 2024 | 2775 | 0.190 |
Why?
|
| Colony Count, Microbial | 3 | 2012 | 328 | 0.180 |
Why?
|
| Parasitic Diseases | 1 | 2021 | 76 | 0.180 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2001 | 53 | 0.180 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2004 | 343 | 0.180 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2020 | 39 | 0.180 |
Why?
|
| Fungi | 1 | 2003 | 338 | 0.180 |
Why?
|
| Peroxidase | 2 | 2021 | 604 | 0.180 |
Why?
|
| Restriction Mapping | 8 | 1997 | 852 | 0.180 |
Why?
|
| Contact Tracing | 2 | 2014 | 268 | 0.180 |
Why?
|
| Blood Bactericidal Activity | 6 | 2012 | 126 | 0.180 |
Why?
|
| Carrier Proteins | 4 | 1999 | 4938 | 0.170 |
Why?
|
| RNA, Messenger | 11 | 2016 | 12762 | 0.170 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2000 | 72 | 0.170 |
Why?
|
| Peptide Synthases | 1 | 2000 | 80 | 0.170 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
| Polysaccharides, Bacterial | 4 | 2020 | 574 | 0.170 |
Why?
|
| Metagenomics | 2 | 2021 | 457 | 0.170 |
Why?
|
| Species Specificity | 8 | 2015 | 2413 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9196 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2017 | 1828 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 2005 | 1056 | 0.160 |
Why?
|
| Staphylococcal Infections | 5 | 2007 | 1405 | 0.160 |
Why?
|
| Bacteria | 4 | 2006 | 2196 | 0.160 |
Why?
|
| Blood | 2 | 2011 | 586 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 563 | 0.160 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2017 | 144 | 0.160 |
Why?
|
| Middle Aged | 54 | 2022 | 220175 | 0.150 |
Why?
|
| Membrane Proteins | 5 | 2009 | 7854 | 0.150 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2004 | 144 | 0.150 |
Why?
|
| Gene Library | 4 | 2006 | 1060 | 0.150 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 628 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2020 | 3804 | 0.150 |
Why?
|
| Protozoan Vaccines | 1 | 1997 | 13 | 0.150 |
Why?
|
| Immunoassay | 2 | 2020 | 748 | 0.150 |
Why?
|
| Meningoencephalitis | 1 | 1998 | 83 | 0.150 |
Why?
|
| Molecular Typing | 2 | 2015 | 116 | 0.150 |
Why?
|
| Haiti | 6 | 2017 | 550 | 0.150 |
Why?
|
| Transformation, Bacterial | 2 | 2015 | 77 | 0.150 |
Why?
|
| Leukemia, Myeloid | 2 | 2001 | 696 | 0.150 |
Why?
|
| Alkaline Phosphatase | 6 | 2000 | 865 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 833 | 0.150 |
Why?
|
| Models, Animal | 2 | 2003 | 2117 | 0.150 |
Why?
|
| Cervix Uteri | 1 | 2001 | 585 | 0.150 |
Why?
|
| Culture Media | 3 | 2010 | 899 | 0.150 |
Why?
|
| Shiga Toxin 1 | 9 | 1995 | 42 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2002 | 2755 | 0.140 |
Why?
|
| Hemolysin Proteins | 1 | 1997 | 114 | 0.140 |
Why?
|
| Rabbits | 7 | 2010 | 4773 | 0.140 |
Why?
|
| Lymphocytes | 3 | 2022 | 2612 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 3 | 2012 | 1041 | 0.140 |
Why?
|
| Tropical Medicine | 1 | 2017 | 51 | 0.140 |
Why?
|
| Microbial Viability | 4 | 2011 | 238 | 0.140 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 1997 | 87 | 0.140 |
Why?
|
| DNA Primers | 6 | 2009 | 2819 | 0.140 |
Why?
|
| Cryptococcosis | 3 | 2009 | 103 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 414 | 0.140 |
Why?
|
| DNA Helicases | 1 | 2002 | 854 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 3735 | 0.130 |
Why?
|
| Bacillus anthracis | 2 | 2008 | 122 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 9 | 2015 | 4717 | 0.130 |
Why?
|
| Moths | 2 | 2007 | 81 | 0.130 |
Why?
|
| Endocarditis | 3 | 2001 | 351 | 0.130 |
Why?
|
| Trisaccharides | 1 | 1996 | 49 | 0.130 |
Why?
|
| Urban Population | 1 | 2004 | 2021 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 14 | 2015 | 7400 | 0.130 |
Why?
|
| HLA-DR Antigens | 1 | 2017 | 630 | 0.130 |
Why?
|
| Hybridization, Genetic | 1 | 2015 | 103 | 0.130 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 563 | 0.130 |
Why?
|
| Tetanus Toxin | 1 | 2015 | 46 | 0.130 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 115 | 0.130 |
Why?
|
| Interferon-gamma | 3 | 2014 | 3160 | 0.130 |
Why?
|
| Mutagenesis | 5 | 2002 | 1234 | 0.130 |
Why?
|
| DNA Probes | 1 | 2016 | 551 | 0.130 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2015 | 53 | 0.130 |
Why?
|
| Virulence Factors | 4 | 2011 | 508 | 0.130 |
Why?
|
| Blotting, Southern | 6 | 2001 | 778 | 0.120 |
Why?
|
| Intestinal Mucosa | 4 | 2022 | 3023 | 0.120 |
Why?
|
| Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
| Intestine, Small | 4 | 2012 | 1207 | 0.120 |
Why?
|
| Plasma | 1 | 2018 | 584 | 0.120 |
Why?
|
| Magnetite Nanoparticles | 1 | 2016 | 316 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2004 | 1539 | 0.120 |
Why?
|
| Administration, Cutaneous | 6 | 2020 | 711 | 0.120 |
Why?
|
| Siderophores | 1 | 1994 | 61 | 0.120 |
Why?
|
| Cytotoxins | 2 | 2001 | 153 | 0.120 |
Why?
|
| Receptors, Virus | 2 | 2012 | 639 | 0.110 |
Why?
|
| Cohort Studies | 14 | 2022 | 41317 | 0.110 |
Why?
|
| Sequence Deletion | 5 | 2006 | 1493 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 3 | 2021 | 1189 | 0.110 |
Why?
|
| Biofilms | 2 | 2010 | 622 | 0.110 |
Why?
|
| Fresh Water | 3 | 2009 | 82 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2010 | 1952 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17766 | 0.110 |
Why?
|
| Gelatinases | 2 | 2004 | 88 | 0.110 |
Why?
|
| Protozoan Proteins | 2 | 2011 | 838 | 0.110 |
Why?
|
| DNA Transposable Elements | 7 | 2009 | 752 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 975 | 0.110 |
Why?
|
| Salmonella typhimurium | 2 | 2009 | 344 | 0.110 |
Why?
|
| Vibrio | 1 | 1993 | 43 | 0.110 |
Why?
|
| Genes, Fungal | 2 | 2005 | 439 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 508 | 0.110 |
Why?
|
| Family Health | 3 | 2018 | 1258 | 0.100 |
Why?
|
| Streptococcus | 3 | 1989 | 198 | 0.100 |
Why?
|
| Biliary Tract | 1 | 2013 | 135 | 0.100 |
Why?
|
| Immunization | 5 | 2015 | 1228 | 0.100 |
Why?
|
| Operator Regions, Genetic | 2 | 1990 | 33 | 0.100 |
Why?
|
| Bacteriolysis | 2 | 2013 | 51 | 0.100 |
Why?
|
| Multigene Family | 3 | 2005 | 1079 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 2016 | 507 | 0.100 |
Why?
|
| Chromosome Mapping | 6 | 2010 | 4625 | 0.100 |
Why?
|
| Genes, Viral | 1 | 2013 | 650 | 0.100 |
Why?
|
| Animals, Suckling | 3 | 2020 | 69 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2015 | 3665 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 612 | 0.100 |
Why?
|
| Dehydration | 2 | 2010 | 226 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1208 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 3 | 2015 | 1447 | 0.090 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 241 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2005 | 1765 | 0.090 |
Why?
|
| Cytokines | 6 | 2019 | 7345 | 0.090 |
Why?
|
| Th1 Cells | 3 | 2012 | 1033 | 0.090 |
Why?
|
| Vancomycin | 4 | 2001 | 503 | 0.090 |
Why?
|
| Th2 Cells | 3 | 2012 | 1048 | 0.090 |
Why?
|
| Antitoxins | 3 | 2019 | 80 | 0.090 |
Why?
|
| Virus Shedding | 1 | 2011 | 111 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 1999 | 1228 | 0.090 |
Why?
|
| Mutation | 22 | 2015 | 29950 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 1996 | 1036 | 0.090 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 11902 | 0.090 |
Why?
|
| Evolution, Molecular | 4 | 2017 | 1884 | 0.090 |
Why?
|
| Monocytes | 1 | 2019 | 2574 | 0.090 |
Why?
|
| Germ-Free Life | 3 | 2000 | 187 | 0.090 |
Why?
|
| Oligosaccharides | 1 | 2012 | 405 | 0.090 |
Why?
|
| Agglutination | 2 | 2020 | 41 | 0.080 |
Why?
|
| Minisatellite Repeats | 1 | 2010 | 164 | 0.080 |
Why?
|
| Spirochaetales Infections | 1 | 2009 | 11 | 0.080 |
Why?
|
| Immunization, Secondary | 3 | 2021 | 366 | 0.080 |
Why?
|
| Immunization Schedule | 2 | 2020 | 225 | 0.080 |
Why?
|
| DNA Footprinting | 2 | 2000 | 97 | 0.080 |
Why?
|
| Animals, Newborn | 4 | 2011 | 2671 | 0.080 |
Why?
|
| Glucuronidase | 2 | 2001 | 203 | 0.080 |
Why?
|
| Receptors, Scavenger | 1 | 2009 | 123 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 15766 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15827 | 0.080 |
Why?
|
| Antibiosis | 1 | 2008 | 45 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2018 | 23363 | 0.080 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 82 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1118 | 0.080 |
Why?
|
| Quorum Sensing | 1 | 2010 | 137 | 0.080 |
Why?
|
| Floods | 1 | 2008 | 42 | 0.080 |
Why?
|
| Serotyping | 4 | 2015 | 324 | 0.080 |
Why?
|
| Curriculum | 1 | 2022 | 3722 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 3774 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 2127 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2012 | 593 | 0.080 |
Why?
|
| Vitamin A | 2 | 2008 | 613 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1576 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 2623 | 0.080 |
Why?
|
| Rotavirus | 1 | 2008 | 111 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 785 | 0.070 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2009 | 150 | 0.070 |
Why?
|
| Zinc | 2 | 2008 | 690 | 0.070 |
Why?
|
| Leptin | 1 | 2015 | 1590 | 0.070 |
Why?
|
| Exosomes | 1 | 2011 | 423 | 0.070 |
Why?
|
| Tularemia | 1 | 2007 | 42 | 0.070 |
Why?
|
| Age Distribution | 2 | 2014 | 2893 | 0.070 |
Why?
|
| Cross Reactions | 2 | 2020 | 818 | 0.070 |
Why?
|
| Time Factors | 11 | 2014 | 40133 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2011 | 2698 | 0.070 |
Why?
|
| Francisella tularensis | 1 | 2007 | 62 | 0.070 |
Why?
|
| Acute Disease | 6 | 2018 | 7268 | 0.070 |
Why?
|
| Azlocillin | 2 | 1984 | 19 | 0.070 |
Why?
|
| Vitamin K 3 | 1 | 2006 | 14 | 0.070 |
Why?
|
| Enterococcus faecium | 2 | 2004 | 101 | 0.070 |
Why?
|
| Quinolones | 1 | 2009 | 377 | 0.070 |
Why?
|
| Serum Bactericidal Test | 1 | 2005 | 3 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2014 | 2777 | 0.070 |
Why?
|
| Hemin | 1 | 2006 | 50 | 0.070 |
Why?
|
| Proteomics | 4 | 2016 | 3810 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 795 | 0.070 |
Why?
|
| Caenorhabditis elegans Proteins | 4 | 2009 | 866 | 0.070 |
Why?
|
| Infant, Newborn | 8 | 2024 | 26168 | 0.070 |
Why?
|
| Cells, Cultured | 7 | 2015 | 18968 | 0.070 |
Why?
|
| Anthrax Vaccines | 1 | 2005 | 17 | 0.070 |
Why?
|
| Candida albicans | 1 | 2009 | 378 | 0.060 |
Why?
|
| Th17 Cells | 3 | 2022 | 789 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2368 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1168 | 0.060 |
Why?
|
| Sequence Alignment | 4 | 2012 | 2178 | 0.060 |
Why?
|
| Chemotaxis | 2 | 2006 | 598 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 14656 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2001 | 2509 | 0.060 |
Why?
|
| Lac Operon | 2 | 2015 | 237 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5873 | 0.060 |
Why?
|
| Genomic Library | 1 | 2005 | 189 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2009 | 586 | 0.060 |
Why?
|
| Mice, Inbred ICR | 2 | 2002 | 363 | 0.060 |
Why?
|
| Melanins | 2 | 2007 | 291 | 0.060 |
Why?
|
| Immunologic Techniques | 1 | 2005 | 213 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2011 | 844 | 0.060 |
Why?
|
| Bacterial Capsules | 1 | 2005 | 242 | 0.060 |
Why?
|
| Pedigree | 2 | 2009 | 4577 | 0.060 |
Why?
|
| Mucins | 1 | 2007 | 568 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1549 | 0.060 |
Why?
|
| Bone Marrow | 1 | 1994 | 2918 | 0.060 |
Why?
|
| Risk Factors | 12 | 2022 | 74269 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2021 | 9712 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 1996 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 482 | 0.060 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 176 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5498 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20048 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2003 | 113 | 0.050 |
Why?
|
| Laccase | 1 | 2002 | 8 | 0.050 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2002 | 25 | 0.050 |
Why?
|
| Cryptococcus | 1 | 2002 | 28 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2008 | 2295 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.050 |
Why?
|
| Bacterial Load | 2 | 2014 | 152 | 0.050 |
Why?
|
| Microscopy | 1 | 2007 | 881 | 0.050 |
Why?
|
| Lysogeny | 1 | 2002 | 67 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 94 | 0.050 |
Why?
|
| Haplotypes | 1 | 2009 | 2764 | 0.050 |
Why?
|
| Shigella flexneri | 1 | 2023 | 120 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4355 | 0.050 |
Why?
|
| Anti-Infective Agents | 2 | 2001 | 982 | 0.050 |
Why?
|
| Mannose-Binding Lectin | 1 | 2003 | 146 | 0.050 |
Why?
|
| Survival Analysis | 7 | 2012 | 10185 | 0.050 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22041 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 2010 | 534 | 0.050 |
Why?
|
| Bartonella | 1 | 2001 | 11 | 0.050 |
Why?
|
| Survival Rate | 5 | 2004 | 12806 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3568 | 0.050 |
Why?
|
| Levodopa | 1 | 2002 | 217 | 0.050 |
Why?
|
| Eye | 2 | 2004 | 710 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2009 | 3605 | 0.050 |
Why?
|
| Bone Marrow Purging | 1 | 2001 | 108 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2005 | 568 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2002 | 211 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 653 | 0.050 |
Why?
|
| Incidence | 5 | 2019 | 21378 | 0.050 |
Why?
|
| Genotype | 3 | 2015 | 12959 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2001 | 780 | 0.050 |
Why?
|
| Cattle | 3 | 2015 | 3847 | 0.050 |
Why?
|
| Amikacin | 1 | 1981 | 48 | 0.050 |
Why?
|
| Kanamycin | 1 | 1981 | 64 | 0.050 |
Why?
|
| Aged | 15 | 2024 | 168995 | 0.050 |
Why?
|
| Roseolovirus Infections | 1 | 2001 | 49 | 0.050 |
Why?
|
| Herpesvirus 6, Human | 1 | 2001 | 96 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2021 | 337 | 0.050 |
Why?
|
| Drug Design | 1 | 2006 | 1062 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 732 | 0.050 |
Why?
|
| Life Tables | 2 | 2001 | 365 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2001 | 102 | 0.050 |
Why?
|
| Artificial Gene Fusion | 1 | 2000 | 56 | 0.040 |
Why?
|
| Hospitals | 2 | 2017 | 3929 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 12156 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 412 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 283 | 0.040 |
Why?
|
| Bacterial Infections | 2 | 2000 | 1402 | 0.040 |
Why?
|
| United States | 4 | 2018 | 72363 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2001 | 189 | 0.040 |
Why?
|
| Mycoses | 2 | 2001 | 387 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2003 | 428 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2000 | 161 | 0.040 |
Why?
|
| Rivers | 2 | 2013 | 66 | 0.040 |
Why?
|
| Disasters | 1 | 2006 | 518 | 0.040 |
Why?
|
| Macrophages | 3 | 2009 | 5745 | 0.040 |
Why?
|
| Risk | 3 | 2007 | 9629 | 0.040 |
Why?
|
| Neutrophils | 3 | 2022 | 3770 | 0.040 |
Why?
|
| Alleles | 2 | 2009 | 6900 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 418 | 0.040 |
Why?
|
| Metronidazole | 1 | 2001 | 231 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 2001 | 642 | 0.040 |
Why?
|
| Serum | 2 | 2011 | 211 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 836 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 330 | 0.040 |
Why?
|
| Antigens | 1 | 2005 | 1447 | 0.040 |
Why?
|
| Meningitis, Listeria | 1 | 1998 | 4 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2002 | 453 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 1021 | 0.040 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 265 | 0.040 |
Why?
|
| Inflammasomes | 2 | 2015 | 532 | 0.040 |
Why?
|
| Exotoxins | 1 | 1999 | 121 | 0.040 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 1999 | 93 | 0.040 |
Why?
|
| Anemia, Aplastic | 1 | 2000 | 228 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2004 | 1536 | 0.040 |
Why?
|
| Endotoxins | 1 | 2021 | 521 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1990 | 1544 | 0.040 |
Why?
|
| HeLa Cells | 3 | 1999 | 3105 | 0.040 |
Why?
|
| Genes, Overlapping | 1 | 1998 | 36 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2005 | 1858 | 0.040 |
Why?
|
| Longevity | 2 | 2003 | 1050 | 0.040 |
Why?
|
| Oxacillin | 1 | 1998 | 41 | 0.040 |
Why?
|
| Consensus Sequence | 2 | 1999 | 367 | 0.040 |
Why?
|
| beta-Lactamases | 2 | 2015 | 304 | 0.040 |
Why?
|
| Binding Sites | 3 | 2000 | 6050 | 0.040 |
Why?
|
| Recurrence | 5 | 2004 | 8487 | 0.040 |
Why?
|
| Coagulase | 1 | 1998 | 54 | 0.040 |
Why?
|
| Ofloxacin | 1 | 1998 | 66 | 0.040 |
Why?
|
| Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.040 |
Why?
|
| RNA Stability | 1 | 2000 | 332 | 0.040 |
Why?
|
| Digestive System | 3 | 2004 | 244 | 0.040 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.040 |
Why?
|
| Brain Abscess | 1 | 1998 | 120 | 0.040 |
Why?
|
| Probability | 2 | 2002 | 2476 | 0.040 |
Why?
|
| Staphylococcus | 1 | 1998 | 156 | 0.040 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2000 | 226 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4573 | 0.040 |
Why?
|
| Metagenome | 1 | 2021 | 450 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2000 | 319 | 0.040 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1997 | 67 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2001 | 521 | 0.040 |
Why?
|
| Prospective Studies | 7 | 2018 | 54263 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2018 | 522 | 0.040 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1997 | 78 | 0.040 |
Why?
|
| Biological Evolution | 2 | 2013 | 1074 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 751 | 0.030 |
Why?
|
| Glutamine | 1 | 2000 | 576 | 0.030 |
Why?
|
| Flagellin | 1 | 2017 | 124 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 1999 | 387 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2018 | 238 | 0.030 |
Why?
|
| Ribosomes | 1 | 2000 | 498 | 0.030 |
Why?
|
| Asia | 1 | 2018 | 618 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 6226 | 0.030 |
Why?
|
| Proteins | 1 | 2011 | 6030 | 0.030 |
Why?
|
| Heart Valve Diseases | 3 | 1991 | 1047 | 0.030 |
Why?
|
| P Blood-Group System | 1 | 1996 | 3 | 0.030 |
Why?
|
| Gene Expression | 3 | 2000 | 7592 | 0.030 |
Why?
|
| Hemocytes | 2 | 2007 | 44 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2006 | 2918 | 0.030 |
Why?
|
| Vero Cells | 1 | 1997 | 484 | 0.030 |
Why?
|
| Synteny | 1 | 2015 | 77 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2002 | 1016 | 0.030 |
Why?
|
| Africa | 1 | 2018 | 707 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1996 | 328 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1282 | 0.030 |
Why?
|
| Shellfish | 1 | 1995 | 37 | 0.030 |
Why?
|
| Carbohydrate Conformation | 1 | 1996 | 207 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 14482 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2001 | 821 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2016 | 3764 | 0.030 |
Why?
|
| Sepharose | 1 | 1996 | 105 | 0.030 |
Why?
|
| Chitin | 1 | 2015 | 33 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2220 | 0.030 |
Why?
|
| Transplantation, Autologous | 2 | 2001 | 2120 | 0.030 |
Why?
|
| Periplasm | 1 | 2015 | 40 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 169 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1996 | 410 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 1997 | 388 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2441 | 0.030 |
Why?
|
| Fever | 2 | 2000 | 1618 | 0.030 |
Why?
|
| Rumen | 1 | 2015 | 18 | 0.030 |
Why?
|
| Models, Biological | 3 | 2019 | 9468 | 0.030 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Conjugation, Genetic | 1 | 2015 | 121 | 0.030 |
Why?
|
| Glycosides | 1 | 1996 | 112 | 0.030 |
Why?
|
| Introns | 1 | 1998 | 978 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 878 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 57 | 0.030 |
Why?
|
| Skin Diseases, Bacterial | 1 | 1995 | 68 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6210 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 461 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 418 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2021 | 721 | 0.030 |
Why?
|
| DNA Mutational Analysis | 4 | 1992 | 4109 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2004 | 1711 | 0.030 |
Why?
|
| Sepsis | 1 | 1989 | 2594 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1635 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 2015 | 224 | 0.030 |
Why?
|
| Gels | 1 | 1996 | 419 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 3159 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2015 | 80 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 84 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2001 | 2195 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1997 | 2186 | 0.030 |
Why?
|
| Age Factors | 3 | 2021 | 18415 | 0.030 |
Why?
|
| Bile | 1 | 1995 | 296 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6775 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2017 | 863 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1628 | 0.030 |
Why?
|
| Arabidopsis | 1 | 1997 | 464 | 0.030 |
Why?
|
| Hospitalization | 3 | 2021 | 10761 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 212 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 1993 | 1433 | 0.030 |
Why?
|
| Heme | 1 | 1996 | 313 | 0.030 |
Why?
|
| Prognosis | 5 | 2021 | 29636 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2018 | 12412 | 0.030 |
Why?
|
| Graft vs Host Disease | 4 | 2002 | 3023 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 1993 | 72 | 0.030 |
Why?
|
| Phenotype | 3 | 2003 | 16543 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 2017 | 341 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2010 | 1993 | 0.030 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1995 | 177 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 380 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 787 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 1344 | 0.030 |
Why?
|
| Prophages | 1 | 2013 | 38 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 785 | 0.030 |
Why?
|
| Automation | 1 | 1996 | 581 | 0.030 |
Why?
|
| Logistic Models | 1 | 2008 | 13311 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2424 | 0.030 |
Why?
|
| Mannose-6-Phosphate Isomerase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Rectum | 2 | 2009 | 896 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 761 | 0.030 |
Why?
|
| Genomic Islands | 1 | 2013 | 52 | 0.030 |
Why?
|
| Polymyxin B | 1 | 2012 | 44 | 0.030 |
Why?
|
| Inverted Repeat Sequences | 1 | 2013 | 61 | 0.030 |
Why?
|
| Hemagglutination | 1 | 1992 | 32 | 0.030 |
Why?
|
| Antibodies | 1 | 2021 | 2424 | 0.030 |
Why?
|
| Colon | 1 | 2001 | 1788 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2019 | 1435 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2017 | 699 | 0.030 |
Why?
|
| Temperature | 1 | 1999 | 2221 | 0.030 |
Why?
|
| Dominican Republic | 1 | 2012 | 74 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1606 | 0.030 |
Why?
|
| Viral Load | 1 | 2022 | 3323 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 582 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2001 | 8551 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1594 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2012 | 234 | 0.030 |
Why?
|
| Learning | 1 | 2022 | 1733 | 0.030 |
Why?
|
| Nepal | 1 | 2013 | 301 | 0.030 |
Why?
|
| Placebos | 1 | 2017 | 1672 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1992 | 195 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2015 | 900 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 1992 | 189 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 401 | 0.020 |
Why?
|
| Genomics | 2 | 2018 | 5790 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 1999 | 1013 | 0.020 |
Why?
|
| Cryptosporidium parvum | 1 | 2012 | 37 | 0.020 |
Why?
|
| Family | 2 | 2015 | 3189 | 0.020 |
Why?
|
| Cell Line | 4 | 2012 | 15626 | 0.020 |
Why?
|
| Bacteriophage Typing | 1 | 2011 | 3 | 0.020 |
Why?
|
| Eye Infections, Fungal | 1 | 1992 | 100 | 0.020 |
Why?
|
| Retina | 1 | 2002 | 2635 | 0.020 |
Why?
|
| Disease-Free Survival | 4 | 2004 | 6830 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 580 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 1328 | 0.020 |
Why?
|
| Kinetics | 1 | 2019 | 6378 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2011 | 98 | 0.020 |
Why?
|
| Biological Transport | 2 | 1993 | 2087 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 2192 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1174 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2009 | 238 | 0.020 |
Why?
|
| Ricin | 2 | 1988 | 70 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 1933 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2000 | 4168 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 1993 | 221 | 0.020 |
Why?
|
| Citrates | 1 | 1990 | 136 | 0.020 |
Why?
|
| Shiga Toxin 2 | 1 | 1990 | 21 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2011 | 228 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 679 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8621 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2002 | 3185 | 0.020 |
Why?
|
| History, 18th Century | 1 | 2010 | 207 | 0.020 |
Why?
|
| Candidiasis | 2 | 2009 | 364 | 0.020 |
Why?
|
| Chickens | 1 | 1992 | 859 | 0.020 |
Why?
|
| Hemolysis | 1 | 1992 | 423 | 0.020 |
Why?
|
| Carbon | 1 | 1994 | 669 | 0.020 |
Why?
|
| DNA Topoisomerase IV | 1 | 2009 | 42 | 0.020 |
Why?
|
| Retrospective Studies | 8 | 2004 | 80301 | 0.020 |
Why?
|
| Gentamicins | 1 | 1991 | 252 | 0.020 |
Why?
|
| Publishing | 1 | 2017 | 837 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 645 | 0.020 |
Why?
|
| Erythromycin | 1 | 2010 | 117 | 0.020 |
Why?
|
| Radiography | 1 | 2001 | 6965 | 0.020 |
Why?
|
| Ampicillin | 2 | 1987 | 141 | 0.020 |
Why?
|
| Brachyspira | 1 | 2009 | 3 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 25928 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 296 | 0.020 |
Why?
|
| Zimbabwe | 1 | 2009 | 135 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1992 | 377 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 1996 | 1593 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2012 | 39254 | 0.020 |
Why?
|
| Tetracycline | 1 | 2010 | 224 | 0.020 |
Why?
|
| DNA Gyrase | 1 | 2009 | 85 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2013 | 658 | 0.020 |
Why?
|
| DNA | 2 | 2015 | 7236 | 0.020 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 93 | 0.020 |
Why?
|
| Echocardiography | 1 | 2001 | 4980 | 0.020 |
Why?
|
| Solubility | 1 | 1990 | 1088 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 469 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 443 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1792 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3086 | 0.020 |
Why?
|
| Bacterial Translocation | 1 | 2008 | 73 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 323 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2013 | 872 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4357 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 513 | 0.020 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1987 | 8 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1746 | 0.020 |
Why?
|
| Penicillins | 3 | 1991 | 403 | 0.020 |
Why?
|
| Cefamandole | 1 | 1987 | 9 | 0.020 |
Why?
|
| Shigella dysenteriae | 1 | 1987 | 14 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2008 | 98 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 2009 | 312 | 0.020 |
Why?
|
| Malnutrition | 1 | 2014 | 638 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 747 | 0.020 |
Why?
|
| Sheep | 1 | 1990 | 1441 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 241 | 0.020 |
Why?
|
| Toxoids | 1 | 2007 | 12 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10434 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1992 | 3969 | 0.020 |
Why?
|
| Lepidoptera | 1 | 2007 | 24 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 877 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1987 | 452 | 0.020 |
Why?
|
| Water Microbiology | 1 | 2007 | 115 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2009 | 371 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 149 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 348 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1988 | 575 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 662 | 0.020 |
Why?
|
| Length of Stay | 1 | 2000 | 6472 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1998 | 858 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 395 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22025 | 0.020 |
Why?
|
| Penicillin Resistance | 2 | 1983 | 82 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1988 | 778 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 553 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1190 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 666 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2009 | 64947 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2004 | 11708 | 0.020 |
Why?
|
| Prevalence | 2 | 2015 | 15687 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2015 | 2861 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 3442 | 0.020 |
Why?
|
| Larva | 1 | 2007 | 509 | 0.020 |
Why?
|
| Heart Block | 1 | 1986 | 392 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2007 | 729 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2005 | 114 | 0.020 |
Why?
|
| Mezlocillin | 1 | 1984 | 3 | 0.020 |
Why?
|
| Moxalactam | 1 | 1984 | 10 | 0.020 |
Why?
|
| Cefoperazone | 1 | 1984 | 7 | 0.020 |
Why?
|
| Cefotaxime | 1 | 1984 | 35 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2486 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1987 | 897 | 0.010 |
Why?
|
| Piperacillin | 1 | 1984 | 37 | 0.010 |
Why?
|
| Peroxidases | 1 | 2004 | 135 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 2004 | 4814 | 0.010 |
Why?
|
| Aminoglycosides | 1 | 1984 | 163 | 0.010 |
Why?
|
| Cross Infection | 1 | 1993 | 1434 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 1986 | 409 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7468 | 0.010 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 1983 | 26 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1845 | 0.010 |
Why?
|
| Peptidyl Transferases | 1 | 1983 | 55 | 0.010 |
Why?
|
| Hexosyltransferases | 1 | 1983 | 58 | 0.010 |
Why?
|
| Clavulanic Acids | 1 | 1982 | 11 | 0.010 |
Why?
|
| Carbenicillin | 1 | 1982 | 15 | 0.010 |
Why?
|
| Clavulanic Acid | 1 | 1982 | 19 | 0.010 |
Why?
|
| Thienamycins | 1 | 1982 | 29 | 0.010 |
Why?
|
| Sulbactam | 1 | 1982 | 31 | 0.010 |
Why?
|
| Imipenem | 1 | 1982 | 37 | 0.010 |
Why?
|
| Massachusetts | 1 | 1995 | 8805 | 0.010 |
Why?
|
| Penicillanic Acid | 1 | 1982 | 41 | 0.010 |
Why?
|
| Tissue Donors | 2 | 2004 | 2314 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2716 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3096 | 0.010 |
Why?
|
| Gastric Acid | 1 | 2002 | 98 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 1246 | 0.010 |
Why?
|
| Americas | 1 | 2001 | 111 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1981 | 34 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3421 | 0.010 |
Why?
|
| Pregnancy | 3 | 2015 | 29725 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2316 | 0.010 |
Why?
|
| Bacteriocins | 1 | 2001 | 89 | 0.010 |
Why?
|
| Blood Group Incompatibility | 1 | 2002 | 135 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2005 | 1616 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1984 | 1705 | 0.010 |
Why?
|
| Gram-Positive Bacteria | 1 | 2001 | 178 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1980 | 71 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2005 | 746 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4554 | 0.010 |
Why?
|
| Graft Survival | 2 | 2001 | 3793 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1981 | 303 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1986 | 2363 | 0.010 |
Why?
|
| Skin Diseases | 2 | 1997 | 1089 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3443 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2000 | 514 | 0.010 |
Why?
|
| Streptococcus pyogenes | 1 | 2001 | 294 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 93 | 0.010 |
Why?
|
| ras Proteins | 1 | 2004 | 1051 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9497 | 0.010 |
Why?
|
| Bacillus subtilis | 1 | 2001 | 352 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2004 | 2702 | 0.010 |
Why?
|
| Splenectomy | 1 | 1999 | 391 | 0.010 |
Why?
|
| Mitral Valve | 1 | 1986 | 1486 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11064 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1982 | 1426 | 0.010 |
Why?
|
| Cytarabine | 1 | 1999 | 696 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 26912 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4358 | 0.010 |
Why?
|
| Heart Failure | 1 | 2001 | 11835 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 294 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1999 | 778 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1989 | 2526 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1981 | 1755 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 1980 | 335 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1992 | 1387 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1986 | 1996 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2002 | 1369 | 0.010 |
Why?
|
| Reoperation | 1 | 1986 | 4292 | 0.010 |
Why?
|
| Cell Survival | 2 | 1999 | 5796 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2001 | 732 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1980 | 497 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 1613 | 0.010 |
Why?
|
| Remission Induction | 1 | 2001 | 2394 | 0.010 |
Why?
|
| Pneumonia | 1 | 1987 | 2138 | 0.010 |
Why?
|
| Sex Factors | 2 | 1986 | 10530 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2009 | 4404 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 1699 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2009 | 8018 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1755 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2866 | 0.010 |
Why?
|
| Developing Countries | 1 | 2006 | 2880 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 2721 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2010 | 58947 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 1980 | 753 | 0.010 |
Why?
|
| Software | 1 | 1986 | 4420 | 0.010 |
Why?
|
| Fungemia | 1 | 1992 | 58 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1993 | 385 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 1001 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2002 | 2906 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6131 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1980 | 912 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1986 | 4896 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1992 | 243 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 1991 | 420 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 24086 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8641 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1980 | 1915 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1980 | 1647 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1991 | 6499 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1980 | 2093 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 1694 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1997 | 1301 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2001 | 8553 | 0.000 |
Why?
|
| Pneumococcal Infections | 1 | 1993 | 503 | 0.000 |
Why?
|
| Protein Binding | 1 | 2000 | 9336 | 0.000 |
Why?
|
| Trypsin | 1 | 1988 | 496 | 0.000 |
Why?
|
| Lactams | 1 | 1987 | 154 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 12532 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2002 | 9283 | 0.000 |
Why?
|
| Glutamates | 1 | 1988 | 391 | 0.000 |
Why?
|
| Retinal Diseases | 1 | 1992 | 702 | 0.000 |
Why?
|
| Registries | 1 | 2001 | 8449 | 0.000 |
Why?
|
| Creatinine | 1 | 1991 | 1906 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1987 | 1388 | 0.000 |
Why?
|
| Cephalothin | 1 | 1983 | 35 | 0.000 |
Why?
|
| Penicillin G | 1 | 1983 | 41 | 0.000 |
Why?
|
| Protoplasts | 1 | 1983 | 44 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 2651 | 0.000 |
Why?
|
| Actins | 1 | 1990 | 2049 | 0.000 |
Why?
|
| Urine | 1 | 1983 | 363 | 0.000 |
Why?
|
| Penicillin-Binding Proteins | 1 | 1983 | 148 | 0.000 |
Why?
|
| Seizures | 1 | 1993 | 2916 | 0.000 |
Why?
|
| Boston | 1 | 1993 | 9282 | 0.000 |
Why?
|
| Hospital Mortality | 1 | 1993 | 5420 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1988 | 5120 | 0.000 |
Why?
|
| Kidney | 1 | 1991 | 7072 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1987 | 6413 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1983 | 3683 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 8058 | 0.000 |
Why?
|